Skip to main content

MoneyWorks4Me

Ennature Bio Pharma - Quaterly Results

13 Nov 2026 Evaluate
The Sales for the quarter ended September 2026 of Rs. 784.59 millions rose by 44.92% from Rs. 541.41 millions.The Total Profit for the quarter ended September 2026 of Rs. 48.86 millions grew from Rs.-12.84 millionsOP of the company witnessed a marginal growth to 103.37 millions from 60.38 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202609 202509 % Var
Sales 784.59 541.41 44.92 784.59 541.41 44.92 784.59 541.41 44.92
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 103.37 60.38 71.20 103.37 60.38 71.20 103.37 60.38 71.20
Interest 0.25 37.89 -99.34 0.25 37.89 -99.34 0.25 37.89 -99.34
PBDT 103.12 22.49 358.51 103.12 22.49 358.51 103.12 22.49 358.51
Depreciation 37.01 36.11 2.49 37.01 36.11 2.49 37.01 36.11 2.49
PBT 66.11 -13.62 -585.39 66.11 -13.62 -585.39 66.11 -13.62 -585.39
TAX 17.25 -0.78 -2311.54 17.25 -0.78 -2311.54 17.25 -0.78 -2311.54
Deferred Tax 9.07 -0.78 -1262.82 9.07 -0.78 -1262.82 9.07 -0.78 -1262.82
PAT 48.86 -12.84 -480.53 48.86 -12.84 -480.53 48.86 -12.84 -480.53
Equity 111.71 111.71 0.00 111.71 111.71 0.00 111.71 111.71 0.00
PBIDTM(%) 13.18 11.15 18.14 13.18 11.15 18.14 13.18 11.15 18.14
Peers
Company Name CMP
Sun Pharma. Inds. 1900.95
Dr. Reddys Labs. 1389.95
Cipla 1412.70
Lupin 1986.70
Zydus Lifesciences 1199.00
View more..